PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance requirement, HSA/FSA eligibility, and nationwide access across all fifty states
Genetic variants affecting GLP-1 and GIP receptor sensitivity do not predict exact medication response or guaranteed side effect avoidance, but they can support a more informed conversation about which GLP-1 option, dose strength, and escalation schedule might align with your biological profile
CNS Drugs (2019) 33(3):20923
However, coverage varies widely between insurance plans
Dundon M, Madden O, Comizzoli P (2019) Three-dimensional culture of endometrial cells from domestic cats: A new in vitro platform for assessing plastic toxicity
The approval is based on data from the randomized, open-label Phase III PAPILLON trial that showed the Rybrevant-based regimen cut the risk of disease progression or death by 60% versus chemotherapy alone